Atul Gawande, who in 2018 was appointed CEO of Haven, the nonprofit healthcare undertaking released by the founders of Amazon, JP Morgan Chase & Co. and Berkshire Hathaway, is in “highly developed conversations” to phase down from the function, according to a Dow Jones report.
WHY IT Matters
Dr. Gawande, a surgeon and Harvard professor, was tapped to direct the then-unnamed joint undertaking just about two yrs back in 2018. Haven’s significantly-publicized debut positioned it as a disruptive pressure in the healthcare field that would harness engineering to decreased prices and increase the high-quality of treatment.
The Dow Jones report quoted unnamed resources expressing Gawande, who is also an writer and New Yorker contributor, had been hunting for someone to enable control operations soon after the chief operating officer departed past year. It mentioned that, for all his healthcare bona fides, he had “very little history in the operational nitty